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The Impact of Duration versus
Extent of TCR Occupancy on T Cell Activation:
A Revision of the Kinetic Proofreading Model
rates for the TCR could have biologically different out-
comes based on the time it takes for T cells to commit to
successive activation events (Germain and Stefanova,
1999; Lyons et al., 1996; Madrenas and Germain, 1996;
McKeithan, 1995; Rabinowitz et al., 1996a). Since step-
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time required to complete formation of a fully competentUnited Kingdom
signaling complex could enable the TCR to discriminate
between high- and low-affinity ligands. This has been
indirectly supported by multiple reports showing a broadSummary
correlation between the duration of TCR/ligand interac-
tion and ligand potency (for recent reviews, see DavisThe widely accepted kinetic proofreading theory pro-
et al., 1998; Germain and Stefanova, 1999; Gascoigneposes that rapid TCR dissociation from a peptide/MHC
et al., 2001). However, there are numerous exceptionsligand allows for stimulation of early but not late T
to the rule that the hierarchy of TCR-ligand affinity and/cell activation events, explaining why low-affinity TCR
or off rates predict ligand efficacy (Al-Ramadi et al.,ligands are poor agonists. We identified a low-affinity
1995; Alam et al., 1996; Baker et al., 2000; Degano etTCR ligand which stimulated late T cell responses but,
al., 2000; Kersh et al., 1998b; Sykulev et al., 1998), thoughcontrary to predictions from kinetic proofreading, inef-
whether these are true exceptions to the kinetic proof-ficiently induced early activation events. Furthermore,
reading model or point to the complexity of interpretingresponses induced by this ligand were kinetically de-
functional assays for T cell activation is unclear.layed compared to its high-affinity counterpart. Using
Even assuming that kinetic proofreading is generallypeptide/MHC tetramers, we showed that activation
valid, the impact that subtle alterations in TCR bindingcharacteristics could be dissociated from TCR occu-
kinetics might have on the cascade of T cell activationpancy by the peptide/MHC ligands. Our data argue
events has not been fully explored. The kinetic proof-
that T cell responses are triggered by a cumulative
reading/discrimination models explicitly predict that
signal which is reached at different time points for
rapid dissociation of the TCR from its ligand can induce
different TCR ligands. early signaling events while later events, requiring a sus-
tained TCR signal, would not occur (McKeithan, 1995;
Introduction Rabinowitz et al., 1996a; Germain and Stefanova, 1999).
However, an alternative model emerges from consider-
Variants of antigenic peptide/MHC ligands can have ing the rapid reversibility of early activation events (e.g.,
drastically altered capacities to induce T cell responses, phosphorylation events) compared to later, more com-
leading to their classification as T cell receptor (TCR) mitted T cell responses (such as gene transcription and
partial agonists and antagonists (Germain and Ste- proliferation). In this case, low-affinity ligands might in-
fanova, 1999; Jameson and Bevan, 1995; Kersh and duce very transient (and thus undetectable) early activa-
Allen, 1996). With some exceptions, the spectrum of tion events while still allowing for commitment to late
biologic activities elicited by peptide/MHC ligands cor- activation events.
relates with this binding affinity for the TCR—the higher To more rigorously test the kinetic proofreading model
the affinity (or slower the off rate), the better the ligand and its consequences for the nature of T cell responses,
is at inducing T cell responses. These findings have led we analyzed the kinetics of T cell activation induced by
to the kinetic proofreading and kinetic discrimination high- versus low-affinity agonist ligands for the OT-I
models of T cell activation, which propose to explain TCR. We found that both types of ligand induced late
how ligands with apparently minor differences in off T cell responses in naı¨ve OT-I T cells, but that activation
by the low-affinity ligand was delayed by several hours
even when analyzed at equivalent TCR occupancy (de-5 Correspondence: james024@tc.umn.edu
termined using tetrameric peptide/MHC ligands). Strik-6 Present Address: Duke University Medical Center, Durham, North
Carolina 27710. ingly, early activation events were efficiently induced
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Table 2. Dissociation Kinetics of Tetrameric Ligands from OT-I CellsTable 1. Kinetics of OT-I TCR Binding to Peptide/Kb Ligand Mea-
sured by SPR at 25C and 37C
t1/2 (min) without B20 t1/2 (min) with B20
antibody antibodykon koff Kd (koff/kon) t1/2
Ligand (M1 s1) (s1) (M) (s)
Experiment G4/Kb OVA/Kb G4/Kb OVA/Kb
Binding at 25C
1 21.0 77.0 2.2 4.8G4/Kb 900 0.009 10.0 77.0
2 31.5 138.6 2.8 10.3OVA/Kb 3400 0.018 5.3 38.5
3 31.5 115.5 1.1 6.8Binding at 37C
Mean  SD 28.0  6.1 110.4  31.1 2.0  0.9 7.3  2.8G4/Kb 1900 0.010 5.3 69.3
OVA/Kb Step 1 2780 0.027 9.7 OT-I T cells were incubated with either G4/Kb (50 g/ml) or OVA/Kb
Step 2 530 0.0012 2.3 577.6 (10 g/ml) tetramers on ice and then incubated at 37C in the pres-
ence of cytochalasin D with or without the anti-Va2 antibody, B20,Surface plasmon resonance data were generated at 25C or 37C
specific for the OT-I TCR. Tetramer staining was analyzed at varioususing soluble OT-I TCR and immobilized peptide/MHC complexes
time points after the 37C incubation, and half-lives for tetrameras described previously (Alam et al., 1999). Binding kinetics were
dissociation were determined from plots of the natural logarithm ofcalculated as described in Experimental Procedures.
the median fluorescence intensity versus time. The data from three
independent experiments are shown.
by the high- but not the low-affinity ligand. Thus, we
demonstrate that some low-affinity TCR ligands are less
intermediate between that for OVA/Kb and a series ofefficient at inducing proximal activation events than dis-
OT-I TCR antagonist ligands (Alam et al., 1999).tal T cell responses. These data reverse predictions from
Although these data define the inherent OT-I affinityprevious formulations of the kinetic proofreading/dis-
for OVA/Kb and G4/Kb, we have previously employedcrimination models and support a revised kinetic proof-
peptide/MHC tetramers to show that CD8 plays a criticalreading model for T cell activation in which signals
role in OT-I TCR engagement to both OVA/Kb and G4/Kb“trickle through” the early activation cascade and accu-
(Daniels and Jameson, 2000). In order to assess themulate to induce later T cell responses.
relative binding of these ligands to intact OT-I cells, we
used fluorescent peptide/MHC tetramers to compare
Results the dissociation rates of OVA/Kb and G4/Kb from live
cells. Based on the approach used by others (Busch
G4/Kb Is a Low-Affinity Ligand for the OT-I TCR and Pamer, 1999; Savage et al., 1999), we prestained
The OT-I TCR is specific for an ovalbumin peptide, OT-I T cells with tetrameric peptide/MHC complexes
OVAp, in the context of the MHC class I molecule, Kb. An and then monitored tetramer dissociation over time at
OVAp variant ligand, G4/Kb, was initially characterized 37C. Cytochalasin D and a blocking antibody to the OT-I
as a weak agonist/antagonist for OT-I CTLs, based on TCR (V2) were added during the dissociation phase to
cytolysis (Jameson et al., 1993). Surprisingly, however, prevent tetramer internalization and rebinding, respec-
G4/Kb was unable to activate either calcium mobilization tively. We observed that OVA/Kb tetramer dissociated
or CD69 upregulation in naı¨ve OT-I T cells, while OVA/Kb from OT-I cells with an average t1/2 of 7.3 min, while
efficiently induced these responses (Davey et al., 1998). G4/Kb dissociated 3.6-fold faster (t1/2 of 2.0 min; Table 2).
In order to understand the basis for these discrepancies In addition, the intrinsic dissociation rate (determined
in G4/Kb-induced stimulation, we undertook a more ex- when V2 antibody was not added to prevent tetramer
tensive analysis of the OT-I TCR interaction with G4/Kb rebinding) showed a similar relative difference between
versus OVA/Kb and the consequences of these interac- the two ligands (Table 2).
tions for OT-I T cell activation. The relative increase in the G4/Kb versus OVA/Kb dis-
Since TCR affinity for ligands correlates with ligand sociation rate measured by tetramer analysis (approxi-
efficacy in the majority of cases (Davis et al., 1998; Gas- mately 4-fold difference) is slightly less than that ob-
coigne et al., 2001), we determined the OT-I affinity for tained by SPR at 37C (8-fold difference; Table 1) but
both OVA/Kb and G4/Kb ligands using surface plasmon overall, the two methods gave remarkably similar results
resonance (SPR) measured with a BIAcore biosensor. considering the very different nature of the methods
In these experiments, Kb/peptide complexes were im- used. Together, these data define G4/Kb as a low-affinity
mobilized on the BIAcore sensor chip, and soluble OT-I ligand for the OT-I TCR.
TCR was pumped over the surface. Initial experiments
yielded the surprising result that the OT-I TCR dissocia-
tion rate for G4/Kb was markedly slower than that for G4/Kb Induces Kinetically Delayed OT-I Activation
Initial experiments had identified G4 as a weak agonistOVA/Kb, which would indicate that G4/Kb should be a
highly potent agonist. However, similar to our previous antagonist for OT-I CTL, and so we determined whether
this ligand could activate naı¨ve OT-I T cells. As shownfindings (Alam et al., 1999), we saw dramatically different
outcomes when SPR measurements were determined (Figure 1A), both G4/Kb and OVA/Kb were able to induce
maximal OT-I CD69 upregulation and proliferation, butat physiological temperatures. Here, the OT-I TCR affin-
ity for OVA/Kb is markedly enhanced, as described pre- roughly 1000- to 10,000-fold higher doses of G4 com-
pared to OVAp were required to achieve similar re-viously (Alam et al., 1999), but the binding kinetics for the
weak agonist ligand G4/Kb is barely altered compared to sponses.
These data appeared inconsistent with our previousthe 25C measurements (Table 1). Using these measure-
ments at 37C, the OT-I dissociation rate from G4/Kb is report showing that high-dose G4 was unable to induce
A “Trickle-Through” Model for T Cell Activation
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Figure 1. Dose Response and Kinetics of OT-I Activation by G4/Kb and OVA/Kb
(A) Peptide dose titration for OT-I T cell activation. Peptides at the indicated doses were added to OT-I splenocytes. Upregulation of CD69
(left panel) and proliferation (right panel) were determined at 24 and 48 hr, respectively. CD69 data are shown as percentages of positive OT-I
cells, but mean CD69 expression levels yielded similar curves. Proliferation was determined by [3H]thymidine incorporation. The data are
representative of three independent experiments.
(B) Kinetics of CD69 upregulation induced by G4 and OVAp. OT-I splenocytes were assayed for CD69 expression 3, 8, and 24 hr after the
addition of P815p or G4 (at doses of 10 M, 100 nM, or 1 nM as indicated on the x axis) or OVAp (10 nM, 100 pM, or 1 pM). A representative
experiment of three is shown.
CD69 upregulation on naı¨ve OT-I cells (Davey et al., (Figure 1), it was possible that, even at high-peptide
concentrations, the occupancy of the OT-I TCR by G4/Kb1998). However, that study measured CD69 upregulation
never reached levels similar to that of OVA/Kb due simplyat 3 hr, rather than at 24 hr as shown in Figure 1A.
to a limited capacity to load “empty” Kb molecules withHence, we explored the kinetics of CD69 upregulation
exogenously added peptides. These issues are difficultin response to OVAp versus G4. This revealed that al-
to address using a conventional presentation of peptide/though the magnitude of the OT-I CD69 responses to
MHC ligands by APCs and thus, we employed soluble,G4 and OVAp (in their respective dose-response ranges)
tetrameric forms of both the G4/Kb and OVA/Kb ligands.was similar at 24 hr, the response to G4 was significantly
Multimeric peptide/MHC ligands can efficiently stimu-delayed, lagging behind the response to OVAp by at
late T cells (Boniface et al., 1998; Cochran et al., 2000;least 5 hr (Figure 1B). A similar lag in the proliferative
Daniels and Jameson, 2000; Wang et al., 2000), whileresponse of OT-I cells was observed, as measured by
at the same time they can tag the cells currently engag-CFSE dye dilution assays (data not shown). These differ-
ing the TCR ligand.ences did not appear to relate to the nature of the APC,
OT-I cells were stimulated with fluorescently conju-since experiments using a dendritic cell line which con-
gated peptide/Kb tetramers or, for comparison, withstitutively expresses costimulation molecules also re-
peptide antigen presented by splenic APC and thenvealed a lag in OT-I response to G4 versus OVAp (data
analyzed for CD69 upregulation (Figure 2A). Both proto-not shown). These data indicated that G4/Kb was fully
cols induced efficient and specific activation of OT-Icapable of inducing OT-I activation, but that the time
cells. Most importantly, there were similar kinetic delaysfor commitment to activation was lengthened compared
in the CD69 upregulation response to G4/Kb comparedto stimulation with OVA/Kb.
to OVA/Kb regardless of the method of stimulation.
These results validate the use of tetramers as stimuli in
Delayed OT-I Activation Kinetics Is Not Due further experiments designed to track the basis for the
to Insufficient TCR Occupancy lag in response to the G4/Kb ligand. Since the peptide/
Given that roughly 1000- to 10,000-fold more G4 peptide MHC tetramers were fluorescent, we could determine
the level of TCR/ligand interaction in these experiments.is required to stimulate OT-I cells compared to OVAp
Immunity
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Figure 2. Equivalent Occupancy of OT-1 TCR with Tetrameric Peptide/Kb Complexes Does Not Eliminate the Kinetic Difference in CD69
Induction
(A) Splenic OT-I cells were incubated with OVAp, G4, or P815p peptides (at concentrations of 10 nM, 10 M, and 10 M respectively; left
panels) or with PE-conjugated peptide/Kb tetramers (G4, 50 g/ml; OVA and SIY, 10 g/ml; right panels). For tetramer stimulation, cells were
preincubated with tetrameric ligands for 2 hr on ice before culturing at 37C. After incubation at 37C for the times indicated, the cells were
stained for Thy-1.2 and CD69 and analyzed by FACS. Both the percentage of CD69 cells (upper panels) and the level of CD69 expression
(lower panels) are shown for all CD8/Thy-1.2 cells, regardless of tetramer staining intensity.
(B) Splenic OT-I cells were stimulated with G4/Kb (50 g/ml) or OVA/Kb (10 g/ml) tetramers for 3 hr, as described in (A). Dot plots show
tetramer staining versus CD69 expression levels (on Thy-1.2 cells). Cells with similar tetramer staining levels (1000–1900 fluorescence units
with MFI 1300 and 1400 for G4 and OVA, respectively) were gated, and the expression level of CD69 on these cells is shown in the histograms.
OT-I cells preincubated with G4/Kb or OVA/Kb tetramers ing similar levels of tetramer staining were compared
(Figure 2B). These results indicate that the delay in Ton ice were incubated at 37C for various times, at which
point tetramer binding and CD69 expression were ana- cell activation is not due to differences in the steady-
state occupancy of the TCR but points to kinetic param-lyzed. CD69 upregulation was considerably lower on
OT-I cells incubated with G4/Kb tetramers than on cells eters such as the duration of TCR/ligand interaction as
the basis for the delay with G4 stimulation.incubated with OVA/Kb tetramers, even when cells bear-
A “Trickle-Through” Model for T Cell Activation
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The Altered Peptide Ligand G4/Kb Is Unable to Induce easily detectable calcium flux response, albeit delayed
by about 1 min, presumably due to the time taken forSustained Early Activation Events
To this point, we had shown that relatively stable and sufficient OVA/Kb tetramers to bind OT-I TCRs. Strik-
ingly, high-concentration G4/Kb tetramer was unable tolate activation parameters like CD69 expression and
proliferation were inefficiently stimulated by G4/Kb. provoke a detectable calcium flux response in OT-I cells
(Figure 3C), although binding of G4/Kb tetramer was wellThus, it was possible that G4/Kb, acting as a partial
agonist, might efficiently induce early activation events, above the level of binding seen with the low concentra-
tion OVA/Kb tetramer (Figure 3B). In contrast, the G4/Kbbut might only inefficiently stimulate later responses.
Indeed, several groups have shown that certain partial tetramer was able to induce detectable calcium mobili-
zation in immature OT-I thymocytes, consistent with ouragonists and antagonists provoke proximal activation
events but not later ones (Hemmer et al., 1998; Madrenas previous report (Davey et al., 1998 and data not shown).
This strengthens the conclusion from Figure 2 indicatinget al., 1995; Rabinowitz et al., 1996a; Sloan-Lancaster
et al., 1994; Wulfing et al., 1997), and this is a central that TCR occupancy is not the primary determinant of
T cell activation, and argues that G4/Kb, even as a pre-prediction of the kinetic proofreading/discrimination
models (McKeithan, 1995; Rabinowitz et al., 1996a; Ger- formed multimer, is unable to induce this early activation
event.main and Stefanova, 1999). In this case, we would ex-
pect both OVA/Kb and G4/Kb to efficiently activate proxi- We further investigated this phenomenon by analyz-
ing the activation of the MAP kinase pathways. Similarmal signaling events. On the other hand, G4/Kb might
be unable to sustain OT-I TCR engagement (due to its to calcium mobilization, TCR-dependent activation of
mitogen-activated protein kinases (MAPK) has beenlower affinity), resulting in rapid reversion of signaling
intermediates back into their resting state. In this case, shown to occur transiently (Alberola-Ila et al., 1997; Su
and Karin, 1996). MAPK pathways, which are importantwe might expect to see the opposite result, namely,
negligible appearance of early activation intermediates, for T cell activation, include ERK, JNK, and p38 (Acuto
and Cantrell, 2000; Alberola-Ila et al., 1997). Using intra-but nevertheless induction of such pathways for later
activation responses. cellular staining for phosphorylated forms of ERK, p38,
and JNK, we could detect a rapid but sustained OT-IWork from a large number of groups has shown that
TCR antagonists and partial agonists are incapable of response toward OVAp compared to the control peptide
(P815p; Figure 4). This response was observed at aninducing “full” phosphorylation of the TCR chain, which
has been used to strengthen the idea that abortive early OVAp dose of 10 nM (Figure 4) and even at 1 nM (data
not shown). In stark contrast, exposure to 1,000- toactivation events may be the basis by which T cell activa-
tion is blocked or altered by such ligands (reviewed by 10,000-fold higher concentration of G4 (10 M) did not
detectably stimulate activation of the MAP kinase path-Sloan-Lancaster and Allen, 1996; reviewed by Germain
and Stefanova, 1999). We determined the TCR chain ways at any time point studied (from 5 min to 1 hr; Figure
4), despite the fact that the doses of OVAp and of G4tyrosine phosphorylation patterns induced by both
OVA/Kb and G4/Kb ligands, using a T cell hybridoma used induced equivalent upregulation of CD69 by 8–12
hr (Figures 1 and 2 and data not shown). The flow cyto-expressing the OT-I receptor. These data (Figure 3A)
reveal that the G4/Kb ligand was unable to induce full metric approach is useful, since any rare OT-I cells un-
dergoing “full” activation after G4/Kb stimulation wouldTCR chain phosphorylation (determined by the appear-
ance of the pp23 form of TCR) and only weakly induced be detected as a subset showing strong induction of
MAPK phosphorylation; such a subset was not apparentthe partially phosphorylated (pp21) form, compared with
OVA/Kb stimulation. Appearance of the pp21 form of at any time point. However, we also tested the induction
of ERK phosphorylation by a standard Western blot withTCR is typically associated with TCR antagonists or
partial agonists (Germain and Stefanova, 1999; Sloan- similar results, namely that OVAp stimulation induced
easily detectable and sustained production of pERKLancaster and Allen, 1996), which is at odds with the
capacity of G4/Kb to induce OT-I stimulation (Figure 1). within 5 min, while G4 did not induce ERK phosphoryla-
tion at this time point or up to 1 hr (data not shown).However, recent studies have shown efficient TCR-medi-
ated stimulation through mutant TCR chains capable Lack of apparent calcium mobilization and MAPK
phosphorylation induced by G4/Kb might mean thatof only partial or no tyrosine phosphorylation (Ardouin
et al., 1999; Liu and Vignali, 1999; van Oers et al., 2000). these intermediates are rapidly reversed, precluding
their detection. Alternatively, G4/Kb might induce a com-Hence, we extended these studies to various down-
stream signaling pathways known to be important in T pletely different activation pathway; indeed, there is
some evidence that TCR ligands can differ in the path-cell activation.
Thus, we studied the calcium flux response, since ways with which they trigger common activation events
(Chen et al., 1998). Evidence against the latter hypothe-we had previously shown that this response could be
induced in naı¨ve OT-I T cells by peptide/MHC tetramers sis came from the finding that induction of CD69 upregu-
lation by both G4/Kb and OVA/Kb appeared similarly sen-(Daniels and Jameson, 2000) and, using flow cytometry,
we could monitor both calcium rise and tetramer binding sitive to various signal transduction inhibitors tested
(cyclosporin A and SB202190; data not shown). Thisin real time. OVA/Kb tetramers added at 1 g/ml (“high”
concentration) bound rapidly to OT-I T cells (Figure 3B) suggests that similar pathways are activated by both
ligands, although we cannot completely rule out alterna-and induced efficient mobilization of intracellular cal-
cium (Figure 3C). Dropping the OVA/Kb tetramer concen- tive pathways. Overall, these data suggest that early
activation events are either very weakly induced or, per-tration by 10-fold (“low” concentration) reduced detect-
able tetramer staining to baseline (only marginally higher haps more likely, rapidly reversed in the case of G4/Kb
stimulation, precluding their detection by normal means.than the control SIY/Kb tetramer), yet there was still an
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Figure 3. G4/Kb Is Inefficient at Stimulating TCR Chain Tyrosine Phosphorylation and Mobilization of Intracellular Calcium
(A) The OT-I T cell hybridoma 58-0T-I was stimulated with P1-32Kb cells with no peptide or after pulsing with OVAp or G4 (10 M). After 30
min, the cells were lysed and TCRs were immunoprecipitated. The upper panel shows a Western blot for phosphotyrosine, and the location
of the TCR pp21 and pp23 forms are indicated. In the lower panel, the blot was stripped and reprobed for total TCR to check for equivalent
immunoprecipitation.
(B and C) Indo-1AM-loaded OT-I cells were analyzed by flow cytometry for 1 min, at which time PE-conjugated peptide/Kb multimers were
added (OVA low, 0.1 g/ml; OVA high, 1 g/ml; G4, 10 g/ml; SIY, 10 g/ml). Analysis of multimer binding (B) and Ca2 mobilization (C) was
determined for the same population of cells. Similar data were obtained in two other experiments.
c-Jun Phosphorylation Is Induced in OT-I These data (Figure 5A) suggested that OVA/Kb but not
G4/Kb multimers induced efficient c-Jun phosphoryla-Cells by Both OVA/Kb and G4/Kb,
but with Different Kinetics tion at this time. However, some weak induction of c-Jun
phosphorylation by G4/Kb was consistently observedActivated JNK phosphorylates c-Jun at serine 63, which
is critical for transcriptional activity of the latter (Smeal (Figure 5A). In further experiments, we studied the time
course of c-Jun phosphorylation. OVA/Kb induced rapidet al., 1991). Naı¨ve OT-1 LN T cells were incubated with
various concentrations of peptide/MHC tetramers for 15 and unexpectedly sustained production of phospho-c-
Jun lasting for many hours after antigen encounter (Fig-min and then fixed and stained for phospho-c-Jun.
A “Trickle-Through” Model for T Cell Activation
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Figure 4. MAPK Phosphorylation Is Efficiently Induced in OT-I Cells by OVA/Kb but Not G4/Kb
Expression level of phospho-ERK1,2, phospho-p38, and phospho-JNK-1,2 in OT-I T cells.
OT-I splenocytes were incubated with OVA, G4, or P815 (10 nM, 10 M, and 10 M, respectively) at 37C for the indicated minutes. Cells
were then intracellularly stained for the indicated phospho-MAPKs. Shaded profiles are expression levels of phospho-MAPK in CD8 T cells
incubated with G4 or OVA peptide, while the unfilled profiles are the levels in cells incubated with P815p for the same time. Profiles are
representative of three experiments.
ure 5B). In contrast, exposure to G4/Kb did not lead to induction of the T cell response. Through using both
conventional APCs and tetrameric forms of the antigens,the rapid appearance of phospho-c-Jun, but this inter-
mediate did slowly accumulate after several hours (Fig- we could show that these differences are unlikely to be
due to other T cell interactions (e.g., with costimulatoryure 5B). These data suggest that phosphorylated c-Jun,
although a reversible intermediate, can accumulate after molecules) and that the nature and kinetics of the OT-I
T cell response does not correlate with the level of TCRexposure to the low-affinity G4/Kb ligand but that, like
later T cell responses, phospho-c-Jun production is ki- occupancy by the low- and high-affinity ligands nor to
alternative activation pathways stimulated by the twonetically delayed.
ligands.
These data lead to a revised model of kinetic proof-Discussion
reading in which low-affinity ligands such as G4/Kb are
poor at stimulating early transient activation events, butIt has been realized for several years that some TCR
ligands can induce T cell responses while others cannot. that this nonetheless leads to complete T cell response
by trickling through to less reversible downstream sig-Determining the basis for this discrimination is central
to our understanding of the mechanisms involved in T naling intermediates. One result of this is that biochemi-
cal events which are highly reversible (such as mostcell activation. The kinetic proofreading/discrimination
models of T cell activation were proposed to explain how phosphorylation events, MAP kinase activation, and cal-
cium flux) were not detected, probably because theseligands with apparently minor differences in affinities
for the TCR could have profoundly different biologic intermediates in the signaling cascade revert to the inac-
tive state before enough molecules accumulate to allowoutcomes (Germain and Stefanova, 1999; McKeithan,
1995; Rabinowitz et al., 1996a; Wulfing et al., 1997). biochemical detection. Accordingly, tyrosine phosphor-
ylation of TCR chain was weakly induced by G4/Kb, butThese theories all revolve around the concept that short-
term TCR engagement will induce proximal signaling then only of the pp21 form which is associated with
transient signaling by partial agonistic or antagonisticevents but not later T cell responses, due to the revers-
ibility of early activation steps. Indirect support for these ligands (reviewed by Germain and Stefanova, 1999). Ad-
ditionally, preliminary data showed prominent inductionmodels has been obtained by the demonstration that
there is a rough correlation between the duration of of p36 LAT phosphorylation by OVA/Kb, while this was
not apparent with G4/Kb stimulation (P.O.H and S.C.J.,TCR/ligand contact and the biologic efficacy of this in-
teraction (Davis et al., 1998; Germain and Stefanova, unpublished data; data not shown). Downstream signal-
ing events such as c-Jun phosphorylation were not de-1999; Gascoigne et al., 2001), but the mechanism by
which these kinetic differences alter T cell responses is tected after a short stimulation with G4/Kb, but did accu-
mulate after several hours of stimulation (Figure 5). Stillless clear.
In this report, we studied the OT-I T cell response later responses, such as proliferation and new gene
transcription, which by their nature are less rapidly re-toward a low- (G4/Kb) versus a high- (OVA/Kb) affinity
TCR ligand. Although both ligands induce OT-I reactiv- versible, were fully induced in OT-I by G4/Kb but with a
marked delay in their induction.ity, the response toward G4/Kb differs from that toward
OVA/Kb in two key respects: first, the deficit in detectable These results present an important departure from
previous studies which correlated TCR agonist strengthearly activation events and second, the kinetic delay in
Immunity
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Figure 5. Slow Accumulation of Phosph-c-Jun Induced by G4/Kb Stimulation
(A) OT-I cells were incubated with the indicated concentrations of APC-conjugated peptide/Kb multimers (g/ml) at 37 for 15 min. Cells were
fixed and stained for Thy-1.2, CD8, and phospho-c-Jun. The MFI of multimer staining (upper panel) and the percentage of OT-I T cells
A “Trickle-Through” Model for T Cell Activation
67
with the ability to induce successively later activation more transient, leading to such infrequent or rapidly
reversible stimulation of early activation events thatevents. These studies implied that low-affinity TCR li-
gands (e.g., TCR antagonist and partial agonists) could commitment to full T cell reactivity would never occur.
Indeed, this rapid (and hence “invisible”) on/off stimula-only stimulate early activation responses, while high-
affinity ligands would also provoke later responses (Ger- tion of early activation events might be part of the mech-
anism of TCR antagonism.main and Stefanova, 1999; Rabinowitz et al., 1996b;
Wulfing et al., 1997). In direct contrast, the weak agonist Our current data cannot address the mechanism of
this trickle-down signaling, specifically whether the inef-ligand studied here induces early activation events very
weakly, while later responses are induced to the same ficiency of proximal activation events induced by G4/Kb
is due to multiple “weak” TCR signals or rare stronglevel as a strong agonist. This raises the practical point
that analysis of either early or late activation parameters signals which do not trigger detectable early events.
Regardless of whether G4/Kb-induced signals are quali-alone may miss critical aspects of a TCR ligand’s effi-
cacy and suitability for induction of an immune re- tatively or quantitatively attenuated compared to OVA/Kb
stimulation, our data show that both stimuli result in fullsponse. Furthermore, we have studied the response of
OT-I cells to these ligands in vivo. These experiments OT-I activation but with quite distinct kinetics and extent
of signaling intermediate representation.show that while OT-I CD69 upregulation is efficiently
induced by a single low dose of OVA, repeated high Interestingly, recent work from Metzger’s group (pub-
lished after this manuscript was accepted) indicateddoses of G4 are needed to induce a partial response
(data not shown). This argues that the nature and kinet- that certain responses triggered through the FcRI may
escape from kinetic proofreading regulation (Liu et al.,ics of the T cell response to different ligands may have
a critical impact on the efficacy of peptides as vaccines. 2001). The accompanying model suggests that this may
occur via generation of an independent “messenger”Our model highlights the relevance of the tempo and
coordination of proximal signaling events in T cell reac- intermediate (Hlavacek et al., 2001). This messenger is
somewhat analogous to the counter we propose here.tivity (Germain and Stefanova, 1999; Iezzi et al., 1998;
Itoh and Germain, 1997). Specifically, the trickle-through Our revised model of kinetic proofreading might also
explain several reports which appear to contradict themechanism of TCR commitment discussed above is ex-
pected to be far less efficient than the synchronous central correlation between TCR affinity (and/or off rate)
and biological activity (Al-Ramadi et al., 1995; Deganostimulation which would be induced with a higher-affin-
ity ligand (i.e., OVA/Kb). However, the observation that et al., 2000; Sykulev et al., 1998). In these studies, the
kinetics of T cell responses were not studied, which wecells do eventually become fully activated (in vitro and
in vivo) despite this inefficient mechanism suggests that would propose is a better index of a ligand’s “efficacy”
than the ability to induce a response at all. As we havecertain intermediates in the signaling cascade are rela-
tively stable and that they can accumulate and “count” shown here, kinetics of T cell activation is a critical
element in the distinction between responses inducedthe number of effective TCR/ligand engagements. The
concept of a counter is in fact predicted in the original by G4/Kb and OVA/Kb, and we would propose that these
patterns of activation kinetics correspond directly to thekinetic proofreading model (McKeithan, 1995), although
the identity of such a molecule was not proposed. From dissociation kinetics of the TCR/ligand interaction.
By using fluorescent tetrameric peptide/MHC com-this report, a candidate molecule for such a counter is
phosphorylated c-Jun; we observe that phosphorylation plexes, we could directly study the relevance of TCR
occupancy on T cell reactivity to different ligands. Thus,of c-Jun at serine 63 (presumably by JNK) is relatively
high in OT-I cells even up to 8 hr after OVA/Kb encounter we found that G4/Kb tetramers were unable to induce
detectable early activation events or rapid T cell respon-in vitro and is also significantly upregulated 8 hr after
stimulation with G4/Kb. This may be a function of both siveness, even when used at doses which produced
similar or greater OT-I TCR engagement compared toc-Jun phosphorylation and increased c-Jun synthesis,
which also occurs after T cell activation. The counter OVA/Kb tetramers (Figures 2, 3, and 5). This provides
experimental evidence that TCR occupancy does notmolecules (perhaps pc-Jun and others) would act to
“record” cumulative TCR signals, and once a critical correlate with T cell activation, an idea which had hith-
erto been inferred by indirect means (Davis et al., 1998;threshold level has been reached, would commit the T
cell to full reactivity. Using pc-Jun as a model, we would Germain and Stefanova, 1999; Kersh and Allen, 1996;
Madrenas and Germain, 1996). Surprisingly, using pep-propose that the lower limit of effective TCR/ligand half-
life is set by the time required to phosphorylate c-Jun, tide/MHC tetramers in functional assays revealed that
the act of premultimerizing the peptide/MHC ligand isand the lower limit for ligand concentration is set by
the time required to accumulate enough pc-Jun before not sufficient to qualitatively change its ability to trigger
T cell responses compared to conventional presentationdephosphorylation can occur. Thus, our model would
simultaneously explain the delayed kinetics and the on APCs. This result casts doubts on models in which
TCR dimerization per se is suggested to be the physio-lower dose sensitivity of OT-I cells for weak agonists
like G4/Kb. Going further, TCR antagonism could be ex- logical mechanism of T cell activation (Bachmann and
Ohashi, 1999; Cochran et al., 2000). Instead, we wouldplained by the kinetics of TCR interaction being even
expressing phospho-c-Jun (lower panel) were analyzed on the same population of Thy-1.2/CD8 cells.
(B) Expression level of phospho-c-Jun in CD8 T cells after the addition of P815p, G4 (both 10 M), or OVAp (10 nM) to splenic culture from
OT-I mice 1–24 hr after stimulation. Cells were fixed and stained as in (A).
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In Vitro Stimulation and Analyses of Activationhighlight the importance of the duration of monomeric
Splenic and/or LN cells (3–10	 105) from OT-I mice were stimulatedTCR/ligand interactions rather than simply their forma-
with peptide or tetrameric peptide/Kb complexes in flat bottom 96-tion. Likewise, this may account for the ability of G4/Kb
well tissue culture-treated plates. In some experiments, OT-I cells
tetramers to remain bound to OT-I cells longer than were preincubated with tetramer at 4C for 1 hr to allow for tetramer
the minimum time required for the activation of early binding, prior to warming the cells to 37C for the biological re-
sponse. For CD69 analysis, cells were harvested from separate wellssignaling events; although the G4/Kb tetramer is bound
after the indicated times, stained with CD69-FITC, B20-PE, andfor several minutes, we would predict that single TCR
CD8-APC in FACS buffer (PBS, 1% FCS, and 3 mM sodium azide),molecules are bound for much shorter times, limiting
and analyzed by flow cytometry (FACS Calibur, Becton Dickinson).the induced response.
The gates used to determine the percentage of CD69 cells was
The tetramer studies also allow us to address the role based on the (unimodal) CD69 antibody staining of unstimulated
of CD8 binding in the response to G4 versus OVAp. OT-I cells or OT-I cells stimulated with low-dose negative control
peptides (either P815 or SIY). For analysis of cell proliferation,Relative OT-I TCR off rates for G4 versus OVA com-
[3H]thymidine was added for the final 8 hr of a 48-hr OT-I splenocyteplexes were similar when measured by SPR or tetramer
stimulation. Incorporation was determined using an LKB Wallacdissociation, yet tetramer binding involves CD8 partici-
1295-12 harvester (Turku, Finland).pation (Daniels and Jameson, 2000). This suggests that
CD8 involvement does not drastically change the hierar-
TCR Chain Tyrosine Phosphorylation Data
chy of OVA/Kb versus G4/Kb binding, although CD8 func- The antigen-presenting cells, P1.32Kb (7.5 	 105/ml), were loaded
tion may of course be different between the two ligands. overnight with 10 M of OVA or G4 peptides. 5	 107 58.OT-I hybrid-
oma cells were added to the APCs and incubated at 37C for 30The inefficient and delayed responses toward low-
min. TCR complexes were immunoprecipitated from precleared cellaffinity peptide/MHC ligands we report here might also
lysates using the anti-CD3 mAb 2C11 and resolved by SDS-PAGE,have implications for reactivity to self-peptide/MHC li-
followed by electrotransfer to a PVDF membrane (Macherey-Nagel)gands. Recently, several groups have shown that naı¨ve
as described (Stotz et al., 1999; Werlen et al., 2000). Tyrosine-phos-
T cells can slowly proliferate when exposed to self- phorylated proteins were examined using mAb 4G10 (Upstate Bio-
peptide/MHC ligands in a lymphopenic environment (re- technology). The positions of the p21 and p23 forms of phospho- are
shown. Membranes were stripped and the nonphosphorylated formviewed by Goldrath and Bevan, 1999; Surh and Sprent,
of CD3 was determined using the mAb H 146-468.2000). This may be analogous to the slow and delayed
response toward low-affinity TCR ligands discussed in
Intracellular Staining to Detect pMAPK and pc-Junthis report.
Cells were fixed in 4% formaldehyde for 15 min at room temperature.In summary, our data suggest a revised model of ki-
They were blocked using the anti-Fc receptor antibody 2.4G2 and
netic proofreading in which the duration of TCR engage- 10% mouse serum for 20 min on ice, stained for CD8 and Thy-1.2
ment regulates the efficiency with which signals trickle for 30 min on ice, washed twice with staining buffer (PBS, 2% FCS,
and 3 mM sodium azide), and then permeabilized with 0.1% saponinthrough the rapidly reversible early activation pathways
(in PBS and 10% FCS) for 5 min on ice. Phospho-MAPK or phospho-to induce later responses. In this way, both the efficiency
c-Jun was detected by sequentially incubating the cells with mouseand kinetics of T cell activation is regulated by TCR-
anti-phospho-MAPK or anti-phospho-c-Jun, followed by biotinyl-ligand affinity.
ated anti-mouse IgG1 or biotinylated anti-rabbit Ig and finally by
streptavidin-PE. Each of these incubation steps was for 30 min at
Experimental Procedures room temperature with reagents diluted in permeabilization buffer
(PBS containing 0.1% saponin and 2% FCS) and were followed by
Mice and Cells three washes in the same buffer. Samples were analyzed by flow
OT-I mice (Hogquist et al., 1994) and OT-I RAG-1 mice were used. cytometry.
In some experiments, OT-I cells were purified by negative selection
through a Cellect CD8 column (Cytovax Biotechnologies) yielding Determination of Calcium Mobilization
95% pure CD8 OT-I TCR cells (data not shown). The T cell Lymph node cells from OT-I/Rag mice (
95% CD8, V2) were
hybridoma line 58, expressing OT-I and CD8 receptors and loaded with Indo-1, and changes in intracellular calcium levels were
P1.32Kb (a Kb-expressing P815 transfectant) were grown in analyzed by flow cytometry as described (Daniels and Jameson,
IMDM/5% FCS and appropriate antibiotics, as previously described 2000). Briefly, OT-I T cells were loaded with Indo-1 AM at 37C in
(Stotz et al., 1999). RPMI media containing 3% FCS. After washing in the same media,
the cells were run on a FACS Vantage (Becton Dickinson) for 1 min
to establish a baseline FL4/FL5 ratio (reflective of intracellular freePeptides, MHC Tetramers, and Antibodies
calcium levels) for unstimulated cells. FPLC-purified PE-labeledThe properties of the OVAp (amino acid sequence SIINFEKL), G4
peptide/MHC tetramers were added at the indicated doses and the(SIIGFEKL), SIY (SIYRYYGL), and P815p (HIYEFPQL) in the OT-I
changes in FL4/FL5 ratio of the cells were monitored for the followingsystem have been described previously (Jameson et al., 1993; Dan-
4–6 min. At the same time, changes in FL-2 were monitored to detectiels and Jameson, 2000). PE- and APC-labeled tetrameric/Kb ligands
binding of the PE-labeled tetramers to the OT-I T cells.were prepared as described (Daniels and Jameson, 2000) and were
used either with or without purification of multimers by FPLC, with
essentially equivalent results. Determination of Kinetics of TCR/Ligand Binding by SPR
and by Fluorescence Decay of Tetrameric LigandFor flow cytometry, the following antibodies from Pharmingen
were used: CD8 (53-6.7), CD69 (H1.2F3), V2 TCR (B20.1), Thy-1.2 SPR measurements were performed as described (Alam et al., 1996,
1999). Briefly, soluble OT-I TCR and Kb/peptide complexes were(30-H12), biotin-conjugated anti-mouse IgG1 (A85-1), and mouse
IgG1  isotype control (MOPC-21). Anti-phospho-JNK (mouse clone prepared by refolding denatured inclusion bodies produced in bac-
teria, as described (Alam et al., 1996, 1999; Garboczi et al., 1996;G-7) and anti-phospho-serine 63-c-Jun (mouse clone KM-1) are
from Santa Cruz Biotechnology, and anti-phospho-p44/p42 MAPK Zhang et al., 1992). Kb/peptide complexes were immobilized using
maleimide coupling chemistry (Alam et al., 1999; O’Shannessy et al.,(mouse clone E10) and anti-phopho-p38 rabbit antisera are from
New England Biolabs. In data not shown, anti-phospho-ERK from 1992). Anti-MHC mAb demonstrated that the surface was 60%–80%
active. Binding was detected using a BIAcore 2000 instrument atSanta Cruz Biotechnology and anti-phospho-JNK from New En-
gland Biolabs were used to confirm that signals from intracellular either 25C or 37C, as described (Alam et al., 1999). Analyte proteins
were injected at a flow rate of 10–50 l/min in PBS (150 mM NaCl,staining and Western blot were specific.
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0.005% surfactant P20 [pH 7.4]) after equilibration to the appropriate tor requires the multivalent engagement of peptide/MHC ligands.
Immunity 9, 459–466.temperature. Data analysis was performed with BIAevaluation 3.0
(BIAcore). Data were fit to kinetic models as described (Alam et al., Busch, D.H., and Pamer, E.G. (1999). T cell affinity maturation by
1999). Briefly, the G4/Kb data fit to a simple model of analyte-ligand selective expansion during infection. J. Exp. Med. 189, 701–710.
interaction (Langmuir equation); A  B ↔ AB, as did the OVA/Kb
Chen, Y.Z., Lai, Z.F., Nishi, K., and Nishimura, Y. (1998). Modulation
data at 25C. The OVA/Kb interaction at 37C was more complex
of calcium responses by altered peptide ligands in a human T cell
and fit best to a dimerization model; A  B ↔ AB, A  AB ↔ AAB
clone. Eur. J. Immunol. 28, 3929–3939.
(Alam et al., 1999).
Cochran, J.R., Cameron, T.O., and Stern, L.J. (2000). The relationshipFor kinetic determination on live cells, OT-I LN cells were stained
of MHC-peptide binding and T cell activation probed using chemi-with tetramers (G4, 50 g/ml; OVA, 10 g/ml) at a density of 0.5 	
cally defined MHC class II oligomers. Immunity 12, 241–250.106 cells/50 l FACS buffer at 4C for 1.5 hr. Anti-Thy-1.2 was added
and the cells were incubated for an additional 0.5 hr. The cells were Daniels, M.A., and Jameson, S.C. (2000). Critical role for CD8 in T cell
washed 3	 in 5 ml wash buffer (RPMI, 2% FCS, 0.1% NaN3; Savage receptor binding and activation by peptide/major histocompatibility
et al., 1999) and then resuspended to a density of 0.5 	 106 cells/ complex multimers. J. Exp. Med. 191, 335–346.
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the presence or absence of FITC-conjugated antibody to V2, B20 S.C., and Hogquist, K.A. (1998). Pre-selection thymocytes are more
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The half-life of ligand/TCR interaction was calculated from the slope 1867–1874.
of the plot of the natural logarithm of the tetramer stain MFI versus
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